Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-29
2008-01-29
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S112000, C546S152000, C514S311000
Reexamination Certificate
active
11345937
ABSTRACT:
A compound having a structureor a pharmaceutically acceptable salt, or a prodrug thereof is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
REFERENCES:
patent: 4166452 (1979-09-01), Generales, Jr.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 6465486 (2002-10-01), Baxter et al.
patent: 7091232 (2006-08-01), Chow et al.
patent: 2005/0075366 (2005-04-01), Heidelbaugh et al.
patent: WO 92/00073 (1992-01-01), None
patent: WO 01/00586 (2001-01-01), None
Heidelbaugh et al (2005): STN International HCAPLUS database, Columbus (OH), accession No. 2005: 303397.
Ruffolo, Jr., “Alpha-Adrenoreceptors: Molecular Biology, Biochemistry and Pharmacology”, 1991.
Messier et al, “High Throughput Assays of Cloned Adrenergic, Muscarinic, Neurokinin, and Neurotrophin Receptors in Living Mammalian Cells”, 1995, 76, pp. 308-311, Pharmacology & Toxicology.
Conklin et al, Nature, vol. 363, May 20, 1993, pp. 274-276.
Remington's Pharmaceutical Sciences, Mack Publishing Company, 16thEditiion, 1980.
Chow Ken
Harcourt Dale A.
Heidelbaugh Todd M.
Nguyen Phong X.
Allergan Inc.
Johnson Brent A.
Shameem Golam M. M.
Voet Martin A.
LandOfFree
7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3932018